Received Jul 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
patient got an extra dose of Shingrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: patient got an extra dose of Shingrix). The outcome of the extra dose administered was not applicable. Additional Information: GSK receipt date: 02-JUL-2025 The pharmacist reported that a patient got an extra dose of Shingrix because it wasn't in the registry which led to extra dose administration.